Home/Filings/4/0001209191-22-016522
4//SEC Filing

Sauer Paul 4

Accession 0001209191-22-016522

CIK 0001649094other

Filed

Mar 3, 7:00 PM ET

Accepted

Mar 4, 8:53 PM ET

Size

7.4 KB

Accession

0001209191-22-016522

Insider Transaction Report

Form 4
Period: 2022-03-02
Sauer Paul
SVP Process Dev, Manufacturing
Transactions
  • Award

    Common Stock

    2022-03-02+10,00037,125 total
  • Award

    Stock Option (right to buy)

    2022-03-02+60,00060,000 total
    Exercise: $24.79Exp: 2032-03-01Common Stock (60,000 underlying)
Footnotes (2)
  • [F1]Represents the number of shares of Common Stock underlying restricted stock units ("RSUs"). Each RSU represents the contingent right to receive one share of the Issuer's Common Stock. The RSUs vest as to 25% of the shares subject to the award on September 2, 2022 and 12.5% of the shares every six months thereafter.
  • [F2]1/48 of shares subject to the option vest on April 2, 2022, and 1/48 of the shares vest monthly thereafter.

Issuer

Vaxcyte, Inc.

CIK 0001649094

Entity typeother

Related Parties

1
  • filerCIK 0001813796

Filing Metadata

Form type
4
Filed
Mar 3, 7:00 PM ET
Accepted
Mar 4, 8:53 PM ET
Size
7.4 KB